BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 34438209)

  • 21. Construction and biological effects of a redox-enzyme dual-responsive lufenuron nano-controlled release formulation.
    Liang Q; Hou C; Tan Y; Wei N; Sun S; Zhang S; Feng J
    Pest Manag Sci; 2024 Mar; 80(3):1314-1324. PubMed ID: 37903714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorophore-free luminescent double-shelled hollow mesoporous silica nanoparticles as pesticide delivery vehicles.
    Cao L; Zhang H; Zhou Z; Xu C; Shan Y; Lin Y; Huang Q
    Nanoscale; 2018 Nov; 10(43):20354-20365. PubMed ID: 30376015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers.
    Wang Y; Gou K; Guo X; Ke J; Li S; Li H
    Acta Biomater; 2021 Mar; 123():72-92. PubMed ID: 33454385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
    Küçüktürkmen B; Rosenholm JM
    Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous silica nanoparticles for tissue-engineering applications.
    Chen L; Zhou X; He C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1573. PubMed ID: 31294533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Roles of Mesoporous Silica in Safe Pesticide Application by Nanotechnology: A Review.
    Kong XP; Zhang BH; Wang J
    J Agric Food Chem; 2021 Jun; 69(24):6735-6754. PubMed ID: 34110151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
    Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
    Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan/silica: A hybrid formulation to mitigate phytopathogens.
    Saberi Riseh R; Vatankhah M; Hassanisaadi M; Kennedy JF
    Int J Biol Macromol; 2023 Jun; 239():124192. PubMed ID: 36996949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficiency of mesoporous silica/carboxymethyl β-glucan as a fungicide nano-delivery system for improving chlorothalonil bioactivity and reduce biotoxicity.
    Kaziem AE; Yang L; Lin Y; Song Z; Xu H; Zhang Z
    Chemosphere; 2022 Jan; 287(Pt 1):131902. PubMed ID: 34438209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.